Accuri Cytometers locks down $6M in financing, adds 25 positions
Accuri Cytometers, an A-list start-up from Ann Arbor, is pulling in seven figures’ worth of seed capital this month.The company is bringing in $6 million in financing to be used to take its Accuri C6 Flow Cytometer into clinical trials and push it towards commercialization. That should allow it to continue growing at a rapid clip. The company has hired about 25 people over the last year, expanding its staff to 87 employees and a few independent contractors and interns. “Our revenue is growing rapidly,” says Jeff Williams, CEO of Accuri Cytometers. “Our sales are growing rapidly.”Accuri Cytometers, a University of Michigan spin-off, specializes in making the cytometer systems that measure T-cell counts (among other things), which is an instrumental tool in tracking and treating diseases like AIDS and cancer. It is a research field with lots of room to grow in both the near and long term.The firm has been on a tear in recent months, selling its products worldwide. It has attracted a number of new customers.”We expects our growth rate to continue,” Williams says.Source: Jeff Williams, CEO of Accuri CytometersWriter: Jon Zemke
Accuri Cytometers, an A-list start-up from Ann Arbor, is pulling in seven figures’ worth of seed capital this month.
The company is bringing in $6 million in financing to be used to take its Accuri C6 Flow Cytometer into clinical trials and push it towards commercialization. That should allow it to continue growing at a rapid clip. The company has hired about 25 people over the last year, expanding its staff to 87 employees and a few independent contractors and interns.
“Our revenue is growing rapidly,” says Jeff Williams, CEO of Accuri Cytometers. “Our sales are growing rapidly.”
Accuri Cytometers, a University of Michigan spin-off, specializes in making the cytometer systems that measure T-cell counts (among other things), which is an instrumental tool in tracking and treating diseases like AIDS and cancer. It is a research field with lots of room to grow in both the near and long term.
The firm has been on a tear in recent months, selling its products worldwide. It has attracted a number of new customers.
“We expects our growth rate to continue,” Williams says.
Source: Jeff Williams, CEO of Accuri Cytometers
Writer: Jon Zemke
Related Articles
Washtenaw County residents invited to contribute to new 10-year tourism plan
Destination Ann Arbor is inviting residents and local stakeholders to help directly shape the future of tourism in Washtenaw County from 2027-2036.
Recast Leaders aim to revitalize local economies
Ypsilanti and six other Michigan communities are working on building their local economies in the Recast Leaders program. Here’s a look at how the program works.
AI’s impact in Washtenaw County, from tech boom to data centers
Our new three-part series digs into AI’s impacts in Ann Arbor’s tech industry, its utilization in Washtenaw County’s educational world, and the ongoing debate about data centers in several Washtenaw County communities.
